Global Expansion Strategic partnership with Vistatec Life Sciences expands GLOBAL’s multilingual regulatory writing and localization capabilities, enabling faster, more accurate regulatory submissions across multiple geographies. This positions GLOBAL to win cross-border programs from mid-sized biotechs and global pharma firms looking for compliant documentation in diverse languages.

Mid-market Advantage With a lean team and revenue in the mid-range, GLOBAL offers CRO-level expertise with the personal attention of a smaller partner, making it a compelling choice for mid-market biotechs seeking high-touch regulatory strategy, writing, and submission management without mega-CRO overhead.

End to End End-to-end regulatory services enable bundled offerings across regulatory strategy, trial and marketing authoring, lifecycle management, submission project management, and publishing, opening opportunities to upsell comprehensive regulatory programs to existing clients and attract firms seeking a single-provider solution.

Drug and Device Drug and device focus allows cross-sell to companies pursuing drug, device, or combination product submissions, with potential to position GLOBAL as an integrated regulatory partner across modalities and across submission pathways.

Regional Presence Strategic regional presence near Seattle's biotech cluster provides proximity advantages for local and regional startups and growing firms; sales plays include location-based network-building, on-site support, and regional partnerships to accelerate deal closure.